Abstract:Introduction: Pulmonary arterial hypertension (PAH) is a disaster disease characterized by obliterative vascular remodeling and persistent increase of vascular resistance, leading to right heart failure and premature death.Understanding the cellular and molecular mechanisms will help develop novel therapeutic approaches for PAH patients.Hypothesis: Human genome-wide association studies (GWAS) identified that SOX17 locus variants are associated with PAH.SOX17 mutation is also found in patients with PAH.We hypothesis that endothelial SOX17 deficiency contributes to the pathogenesis of PAH.Methods: Mice with EndoSCL-CreERT mediated deletion of Sox17 (Sox17iCKO) were generated.Sox17iCKO and Sox17f/f mice after tamoxifen injection were incubated without or with hypoxia (10% O2) for 3 weeks to induced PH.Hemodynamics and histological examination were measured to determine the PH phenotypes and vascular remodeling.EC proliferation, apoptosis, and cell junction assay were assessed in siRNA-mediated SOX17 knockdown in human lung microvascular endothelial cells (hLMVECs).The RNA-sequencing analysis was performed to understand the molecular mechanisms of SOX17 deficiency in ECs.siRNA and inhibitors were used to determine the involvement of E2F1/BRD4 signaling in SOX17 deficiency ECs.Results: Sox17iCKO mice developed spontaneous mild PH and exaggerated hypoxia-induced PH evident by the increase of RVSP and RV hypertrophy compared to Sox17f/f WT mice.SOX17 knockdown in hLMVECs induced cell proliferation, reduced starvation-induced apoptosis, and impaired cell junction integrity.RNA-seq analysis and pathway analysis demonstrated that there was dysregulation of cell proliferation-related genes, which are enriched in the pathways related to the cell cycle.Transcriptional factor, target, and motif discovery analysis of the dysregulated gene set revealed the involvement of transcriptional factors E2F1.SiRNA mediated knockdown of E2F1 but not FOXM1 normalized SOX17 deficiency-induced hLMVECs proliferation and anti-apoptosis.E2F1 and BRD4 inhibitors attenuated SOX17 deficiency-induced EC dysfunction.Conclusions: Our study demonstrated that endothelial SOX17 deficiency induces PH in mice.Loss of SOX17 promotes EC proliferation and anti-apoptosis via the upregulation of transcription factor E2F1/BRD4 signaling.

Light at the ENDothelium-role of Sox17 and Runx1 in endothelial dysfunction and pulmonary arterial hypertension

SOX17 is a Critical Factor in Maintaining Endothelial Function in Pulmonary Hypertension by an Exosome‐Mediated Autocrine Manner

Epigenetic Regulation of Pulmonary Arterial Hypertension

Endothelial Progenitor Cell-Based Therapy for Pulmonary Arterial Hypertension

Abstract 14257: Endothelial SOX17 Deficiency Induces Pulmonary Arterial Hypertension

Abstract 13304: Sox17 Deficiency Induces Pulmonary Hypertension Through E2F1/BRD4 Signaling

E2F1/BRD4 Signaling Mediates SOX17 Deficiency Induced Pulmonary Hypertension

Unraveling the role of HIF and epigenetic regulation in pulmonary arterial hypertension: implications for clinical research and its therapeutic approach

SOX17 Prevents Endothelial-Mesenchymal Transition of Pulmonary Arterial Endothelial Cells in Pulmonary Hypertension through Mediating TGF-β/Smad2/3 Signaling

Endothelial and Smooth Muscle Cell Interaction Via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension

E2F1 Mediates SOX17 Deficiency–Induced Pulmonary Hypertension

Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension

Updated perspective of EPAS1 and the role in pulmonary hypertension

Endothelial cells in the pathogenesis of pulmonary arterial hypertension

Mechanisms of lung endothelial cell injury and survival in pulmonary arterial hypertension

Lung Capillary Endothelium to Arterial Endothelium Transition in Pulmonary Arterial Hypertension

General Capillary Endothelial Cells Undergo Reprogramming into Arterial Endothelial Cells in Pulmonary Hypertension through HIF-2α/Notch4 Pathway

Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α

Hypoxia-inducible factor signaling in pulmonary hypertension.

Abstract 12497: Diminished Cavolin-1 Expression and Augmented Nitrative Stress Secondary to Prolyl-4 Hydroxylase 2 Deficiency Contribute to Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension